4//SEC Filing
Postma Robert W 4
Accession 0000950170-25-054436
CIK 0001107421other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 8:42 PM ET
Size
9.0 KB
Accession
0000950170-25-054436
Insider Transaction Report
Form 4
Postma Robert W
Director
Transactions
- Award
Common Stock
2025-04-13$2.92/sh+20,804$60,748→ 29,083 total - Purchase
Series A-1 Convertible Preferred Stock
2025-04-11$2.76/sh+500$1,380→ 500 total(indirect: By WaterMill Asset Management Corp.)Exercise: $2.76From: 2025-04-11→ Common Stock (181,159 underlying)
Holdings
- 33,333(indirect: By WaterMill Asset Management Corp.)
Common Stock
- 24(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
- [F2]The preferred stock is perpetual and therefore has no expiration date.
- [F3]The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance.
Documents
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001827847
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 8:42 PM ET
- Size
- 9.0 KB